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Abstract
We investigated whether obsessive–compulsive (OC) symptoms from a population-
based sample could be analyzed to detect genetic variants influencing obsessive–
compulsive disorder (OCD). We performed a genome-wide association studies
(GWAS) on the obsession (rumination and impulsions) and compulsion (checking,
washing, and ordering/precision) subscales of an abbreviated version of the Padua
Inventory (N = 8,267 with genome-wide genotyping and phenotyping). The compul-
sion subscale showed a substantial and significant positive genetic correlation with
an OCD case–control GWAS (rG = 0.61, p = .017) previously published by the Psychi-
atric Genomics Consortium (PGC-OCD). The obsession subscale and the total Padua
score showed no significant genetic correlations (rG = −0.02 and rG = 0.42, respec-
tively). A meta-analysis of the compulsive symptoms GWAS with the PGC-OCD rev-
ealed no genome-wide significant Single-Nucleotide Polymorphisms (SNPs combined
N = 17,992, indicating that the power is still low for individual SNP effects). A gene-
based association analysis, however, yielded two novel genes (WDR7 and ADCK1).
The top 250 genes in the gene-based test also showed a significant increase in
enrichment for psychiatric and brain-expressed genes. S-Predixcan testing showed
that for genes expressed in hippocampus, amygdala, and caudate nucleus significance
increased in the meta-analysis with compulsive symptoms compared to the original
PGC-OCD GWAS. Thus, the inclusion of dimensional symptom data in genome-wide
association on clinical case–control GWAS of OCD may be useful to find genes for
OCD if the data are based on quantitative indices of compulsive behavior. SNP-level
power increases were limited, but aggregate, gene-level analyses showed increased
enrichment for brain-expressed genes related to psychiatric disorders, and increased
association with gene expression in brain tissues with known emotional, reward
processing, memory, and fear-formation functions.
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1 | INTRODUCTION
Obsessive–compulsive disorder (OCD) is characterized by recurrent,
unwanted thoughts (obsessions) and/or repetitive behaviors (compul-
sions). The repetitive behaviors or mental acts (such as hand washing,
ordering, and checking) are performed in response to an obsession or
according to rules that must be applied rigidly. They are aimed at
preventing or reducing the distress of a feared event or situation, a
fear which at the same time is clearly unrealistic and/or excessive.
OCD is associated with considerable suffering and markedly impairs
individuals' social and occupational functioning. The lifetime popula-
tion prevalence of OCD is estimated to be 2–3% (Kessler et al., 2005).
Genetic studies have firmly established that OCD has a significant
heritable component. A family study has shown evidence for
increased odds-ratios in family members of OCD probands (Pauls,
Alsobrook 2nd, Goodman, Rasmussen, & Leckman, 1995). However,
family studies cannot exclude that the shared rearing environment
between family members plays a role in the etiology of the disease,
thus biasing heritability estimates. Twin studies may overcome this
limitation; however, these studies of OCD diagnosis have been limited
in sample size (van Grootheest, Cath, Beekman, & Boomsma, 2005).
Twin studies examining obsessive–compulsive symptoms in the gen-
eral population estimated its heritability to be around 40% (den
Braber et al., 2016; Iervolino, Rijsdijk, Cherkas, Fullana, & Mataix-Cols,
2011; van Grootheest et al., 2005; van Grootheest, Cath, Beekman, &
Boomsma, 2007; Zilh~ao et al., 2015). Overall, these studies suggest
that a modest, but significant proportion of the liability for OCD is
heritable.
OCD is relatively underrepresented in genome-wide association
studies (GWAS), both in sample size and number. The largest case–
control meta-analysis of GWAS to date included ~2,800 cases, which
falls well short of the >40,000 cases for many other psychiatric disor-
ders (International Obsessive Compulsive Disorder Foundation Genet-
ics Collaborative (IOCDF-GC) and OCD Collaborative Genetics
Association Studies (OCGAS) et al., 2018). No significant associations
were reported, likely due to the sample size being smaller than
required for studies of complex disorders. One solution to increase
sample size is to include data from large databases of validated health
questionnaires in individuals that have been genotyped, including
nonclinical, population-based samples with information on obsessive–
compulsive symptoms. This requires that the scores on the question-
naire, or the scores on the subscales, reflect the underlying genetic lia-
bility and thus genetically correlate with the clinically established
diagnosis of OCD. Since very large numbers of participants are a
necessity to identify common genetic variants from GWAS, such self-
report symptom data may be crucial to increase the sample size of the
existing case–control GWASs. For ADHD, it was recently demon-
strated that this is a viable option, provided that the correct statistical
meta-analytic technique is used (Demontis et al., 2019). Here, we aim
to use a similar approach for a GWAS of OCD. We will first run
GWASs on OC symptom scores and subscales from the Padua Inven-
tory and establish whether the genetic variants underlying OC symp-
toms are associated with those underlying OCD (International
Obsessive Compulsive Disorder Foundation Genetics Collaborative
(IOCDF-GC) and OCD Collaborative Genetics Association Studies
(OCGAS) et al., 2018), by estimating their genetic correlation. Sec-
ondly, we will meta-analyze the GWASs on OCD and correlated OC
symptom subscales, to examine whether this results in an increase in




Twins and their family members (parents, children, siblings) registered
at the Netherlands Twin Register (NTR; Boomsma et al., 2002) were
included in the OC symptom analyses. Every 2–3 years subjects who
participate in NTR studies receive self-report surveys, which contain a
variety of questionnaires related to health, personality, demographics,
lifestyle, and psychiatric disorders. Data on OC symptoms were avail-
able for 20,528 subjects (N = 10,285 in the year 2002 and N = 15,803
in the year 2005, with N = 5,560 overlaps). Of these, N = 8,267 (64%
female) had genotype data available and were of Dutch ancestry.
Their mean age was 41.6 years (SD 15.4; age range between 18 and
80 years); Supporting Information Figure S1 shows the age histogram.
Informed consent was obtained from all participants. The study was
approved by the Central Ethics Committee on Research Involving
Human Subjects of the VU University Medical Centre, Amsterdam, an
Institutional Review Board certified by the U.S. Office of Human
Research Protections (IRB number IRB00002991 under Federal-wide
Assurance—FWA00017598; IRB/institute codes, NTR 03-180).
2.2 | Padua-revised (abbreviated) OC symptoms
The OC symptom self-report data were collected by the abbreviated
Dutch translation of the Padua Inventory-Revised (Burns, Keortge,
Formea, & Sternberger, 1996; Cath, van Grootheest, Willemsen, van
Oppen, & Boomsma, 2008; van Oppen, 1992). Supporting Information
Table S1 shows the questions and subscales of the OC symptom
scores. The Padua Inventory-revised separates the worry, thought-
related items from the behavioral, compulsive items. Six items are
included to measure symptoms of impulsive thoughts and rumination.
The remaining six items measure behavioral symptoms of OCD,
namely checking, washing, and precision (ordering, counting). Since
the OC symptoms scale showed strong evidence for skew, we trans-
formed the data with a square-root transformation to minimize the
right skew (Zilh~ao et al., 2015).
2.3 | Genotyping and imputation for OC symptoms
A full description of genotyping, preimputation QC, and imputation of
the NTR OC symptoms GWAS is provided in the Supporting
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Information methods. Several critical steps and parameters are pres-
ented here. Samples were removed if DNA sex did not match the
expected phenotype, if the Plink heterozygosity F statistic was
<−0.10 or >0.10, or if the genotyping call rate was <0.90. SNPs were
removed if the minor allele frequency (MAF) <0.01, if the Hardy–
Weinberg equilibrium p-value <1 × 10–5, if call rate <0.95, or if the N
Mendel errors >20. Palindromic AT/GC SNPs with an MAF range
between 0.4 and 0.5 were removed to avoid possible strand alignment
issues. These were applied to each genotyping platform that was
used. After imputation, the datasets of each genotyping platform were
merged and QC repeated. Ancestry outliers (non-Dutch ancestry)
were defined based on Principal Components Analysis (PCA) by
projecting 10 PCs from 1000G reference Phase 3v5. We finally
filtered on population based and sample MAF filtered at 0.03. Allele-
frequency differences between 1000G reference and sample over
0.20 were removed (10,260 SNPs).
2.4 | GWAS on OC symptoms
We ran GWASs for the total score on the Padua scale, the obsessions
scale, and the compulsions scale with ~4.5 M SNPs in a model with
linear mixed effects correcting for population stratification and the
genetic relatedness between family members, as implemented in
GCTA (Yang, Lee, Goddard, & Visscher, 2011). Sex, age, age2, and
10 population stratification PCs were specified as fixed effects. We
created two types of matrices to model genetic relatedness. The
matrix covered the full genetic relatedness matrix including unrelated
subjects. The second, family-based matrix was created from the first
by setting all relatedness values under 0.05 to zero. This models the
additive genetic effects within and between families separately, thus
correcting for both family dependence and ancestry dependence in
the SNP effects. Both the full genetic relatedness matrix and the fam-
ily matrix were used in the association analysis. We excluded informa-
tion of each chromosome out of the relatedness estimations (leave-
one-chromosome-out method) so as to avoid adding information from
the currently tested SNP in the residual of the linear mixed model.
We inspected LD-score regression intercept estimates to test for ade-
quate control of the complex relatedness in the sample.
2.5 | Meta-analysis of PGC-OCD-EA and OC
symptoms GWAS
We meta-analyzed the results with the PGC-OCD GWAS (International
Obsessive Compulsive Disorder Foundation Genetics Collaborative
(IOCDF-GC) and OCD Collaborative Genetics Association Studies
(OCGAS) et al., 2018) of 2,688 cases and 7,037 controls of European
ancestry. We meta-analyzed this (dichotomous) case–control PGC-OCD
GWAS with the (continuous) OC symptoms GWAS using the genome-
wide association meta-analysis (GWAMA) method described in
(Demontis et al., 2019) and implemented in R. The population prevalence
was set to 0.01 with the actual number of cases and controls entered.
2.6 | SNP heritability
SNP heritability for PGC-OCD and OC-compulsions were established
with LD-score regression (Bulik-Sullivan, Loh, et al., 2015) to estimate
the proportion of variance that could be explained by the aggregated
effect of the SNPs. The method is based on the assumption that a
regression of the phenotype on the SNP dosage includes the effects
of all SNPs in LD with the tested SNP. On average, an SNP that tags
many other SNPs will have a higher probability of tagging a causal var-
iant than one that tags a few other SNPs. Accordingly, for highly poly-
genic traits, SNPs with a higher average LD score have stronger effect
sizes than SNPs with lower LD scores. When regressing the effect size
obtained from the GWAS against the LD score for each SNP, the
slope of the regression line gives an estimate of the proportion of var-
iance accounted for by all analyzed SNPs. Standard LD scores were
used based on the Hapmap 3 reference panel, restricted to European
populations.
2.7 | Genetic correlation
We used cross-trait LD-score regression to estimate the genetic
covariation between traits based on GWAS summary statistics (Bulik-
Sullivan, Finucane, et al., 2015). We chose LD-score regression
genetic correlation estimates as it was found to be reasonably robust
and unbiased (Lee, McGue, Iacono, & Chow, 2018). In addition, LD-
score is often used in large genetic correlation studies
(e.g., Brainstorm Consortium, 2018), which makes our results readily
comparable. The alternative of calculating polygenic score based cor-
relations are strongly biased toward zero for the current sample sizes
and require an independent sample for testing. In LD-score regression,
the genetic covariance is estimated using the slope from the regres-
sion of the product of z-scores from two GWAS studies on the LD
score. The estimate obtained from this method represents the genetic
correlation between the two traits based on all polygenic effects cap-
tured by SNPs. Standard LD scores were used as provided by Bulik-
Sullivan et al. (Bulik-Sullivan, Loh, et al., 2015) based on the 1,000
genomes reference set, restricted to European populations.
2.8 | Gene-based test and enrichment analysis
We performed an MAGMA positional gene-based test of association
based SNP effects around genes with a 10kbp margin around the 30
and 50 UTR as implemented in FUMA (Watanabe, Taskesen, van
Bochoven, & Posthuma, 2017). We performed enrichment tests by
comparing the top 250 genes from the gene-based tests to several
types of annotated gene sets. Ten brain-expression gene sets were
selected in FUMA based on the GTEx v7 database. From these tis-
sues, differentially expressed genes (DEGs) were defined as those
showed significant up- or down-regulation compared to the average
expression in all other 52 tissues. Enrichment of these genes in the
top 250 genes was determined using the hypergeometric test. In
210 SMIT ET AL.
addition, we determined whether sets of GWAS catalog reported
genes were overrepresented in the top 250 genes. Finally, we com-
pared the significance of these tests between the original PGC-OCD
GWAS and the meta-analysis OCD + compulsion symptoms in order
to establish whether stronger enrichment could be obtained.
2.9 | Expression analysis
To examine to what extent genes associated with OCD + compulsion
symptoms meta-analysis are expressed in the brain, we performed
S-Predixcan analysis on the meta-analyzed GWAS results. S-Predixcan
is based on Predixcan (Gamazon et al., 2015). Predixcan uses RNAseq
gene-expression associations present in the GTEx database to build
sparse elastic net models, one model for each pair of the 53 tissues
and ~30,000 genes. Individual SNP data is then used to impute gene
expression. These imputed gene expressions are then associated with
the phenotype, resulting in tissue-specific associations of gene-
expression with the phenotype. S-Predixcan (Barbeira et al., 2018) is
an extension of Predixcan and can be used with summary
statistics only.
3 | RESULTS
3.1 | Genome-wide association studies
Supporting Information Figure S2A–C shows the Manhattan plots for
the obsessions, compulsions, and original PGC-OCD GWASs. The
respective Q–Q plots are shown in Supporting Information -
Figure S3A–C.
3.2 | Compulsive symptoms show significant
genetic correlation with OCD
Table 1 shows the results of the SNP heritability and genetic correla-
tion analysis for the three GWASs using LD-score regression with the
original PGC-OCD. The SNP heritability is consistent with previous
results (den Braber et al., 2016). The compulsions subscale showed an
almost significant heritability at 11.6% (z = 1.88, p = .06). The obses-
sions subscale showed lower heritability and did not approach
significance. The compulsions composite scale (contamination/order-
ing/counting/checking symptoms) showed a substantial and signifi-
cant correlation with the PGC-OCD GWAS (rG = 0.61, p = .017). The
obsessions subscale and the full-scale GWAS did not show a signifi-
cant rG with the PGC-OCD GWAS.
3.3 | Meta-analysis
Because only the compulsion subscale showed significant rG, this sub-
scale was selected for meta-analyzing with the PGC-OCD GWAS.
Supporting Information Figure S2D shows the Manhattan plot for the
OCD + compulsion symptoms meta-analysis. Figure S3D shows the
associated Q–Q, and Figure 1 shows the comparison of the original
PGC-OCD Q–Q to the one for the OCD + compulsion symptoms
meta-analysis. The inflation median lambdas were comparable for the
original and extended GWASs, λ = 1.032 and λ = 1.033, respectively,
indicating a marginally higher lambda for the meta-analysis. Lambdas
for the upper 10% percentile were 1.0205 and 1.0405, respectively,
indicating a difference in inflation for top SNP effects. LD score
regression intercepts were near 1.0 (0.9889, SE = 0.0065 and 0.9937,
SE = 0.0085, for the original PGC-OCD and the OCD + compulsion
symptoms meta-analysis, respectively), indicating successful control of
the ancestry effects.
3.4 | Gene-based tests
Supporting Information figure shows the gene-based Manhattan plot,
and Figure 2 shows the associated Q–Q for the gene-based test
results obtained using MAGMA (de Leeuw, Mooij, Heskes, &
Posthuma, 2015). Four genes were significantly associated with OCD
+ compulsion symptoms meta-analysis after correcting for multiple
testing: KIT, GRID2, WDR7, and ADCK1 at FDR q = 0.05. Of these,
WDR7 and ADCK1 are novel, whereas the other two confirmed find-
ings from the original PGC-OCD GWAS.
3.5 | Altered enrichment of brain-expressed genes
We performed an enrichment test of the top 250 genes from the
MAGMA positional gene-based analysis, scanned for the enrichment
TABLE 1 SNP-based heritability of the Padua Inventory full-scale score GWAS, the compulsions and obsessions subscales, and their genetic
correlation with the PGC-OCD GWAS
Heritability Genetic correlation with PGC-OCD
h2 SE rG SE z p
Compulsions 0.116 0.062 0.61 0.255 2.378 .017
Obsessions 0.058 0.065 −0.02 0.322 −0.068 .946
Full scale 0.102 0.060 0.42 0.254 1.672 .095
Notes: SNP-based heritabilities and genetic correlations were estimated using LD-score regression.
SMIT ET AL. 211
of brain-expressed genes from the GTEx database (v7) and for genes
reported in GWAS catalog (https://www.ebi.ac.uk/gwas/) associated
with psychiatric traits.
Figure 3 shows the significance of enrichment of tissue-specific
genes in original PGC-OCD before (left, in black) and after meta-
analyzing with compulsive symptoms (right, in orange) for all neural
tissues excluding cerebellum and spinal cord. Whole blood and two
brain-unrelated tissues (spleen, stomach) were added for reference.
Brain-tissue DEGs were significantly enriched in the PGC-OCD
GWAS, with the expressed genes in the anterior cingulated cortex
(ACC), nucleus accumbens (NAcc), and amygdala as top significant tis-
sues. ACC, amygdala, frontal cortex, and hippocampus showed strong
increases in significance, indicating that more brain-expressed DEGs
were present in the top 250 genes of the meta-analysis compared to
the original PGC-OCD. Other brain tissues showed marginal change
(caudate, putamen, NAcc, hypothalamus). Other tissues (cortex and
substantia nigra) showed a decrease in effect.
3.6 | Enrichment of psychiatric and behavioral
gene sets
Gene sets from the GWAS catalog are available in FUMA for enrich-
ment analysis. Both the original PGC-OCD GWAS and the meta-
analysis with compulsive symptoms showed a large set of significant
results after Bonferroni correction, including many psychiatric/behav-
ioral traits. Figure 4 shows the −log10(p) of the enrichment tests of
these traits. Schizophrenia genes were strongly enriched, and
F IGURE 1 Q–Q plot of observed SNP p-values against expected
p-values under the null. Black is the original PGC-OCD GWAS, blue is
the meta-analysis of PGC-OCD with compulsions. Dashed line is FDR
q = 0.05 [Color figure can be viewed at wileyonlinelibrary.com]
F IGURE 2 Q–Q plot of observed against expected p-values under
the null of the MAGMA gene-based test. Dashed line is FDR q = 0.05.
The meta-analysis OCD + compulsion symptoms (blue) resulted in
four significant discoveries, KIT, GRID2, WDR7, and ADCK1. The
latter two are novel findings compared to the original PGC-OCD
GWAS (black) [Color figure can be viewed at wileyonlinelibrary.com]
F IGURE 3 Enrichment results for the PGC-OCD (black) and the
OCD + compulsion symptoms meta-analysis (orange). Enrichment of
tissue-specific differentially expressed genes (DEGs) was determined
using the hypergeometric test. The y-axis shows the Bonferroni
corrected significance of the test as –log 10(p). The dashed line
indicates the significance threshold (p = .05). Significance strongly
increased for some brain tissues (over 1 point increase for ACC,
amygdala, hippocampus and frontal cortex), and decreased for others
(over 1 point decrease for cortex, substantia nigra) [Color figure can
be viewed at wileyonlinelibrary.com]
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significantly increased over 3 orders of magnitude for the meta-
analysis. Significance increased also for “Tourette's or OCD” and
“Autism or Schizophrenia” genes. The schizophrenia genes that con-
tributed to the enrichment effect included the KIT gene, as well as
genes on region 3p21 (ITIH4, TMEM112). Genes in this region have
been related to bipolar disorder and schizophrenia as well as brain
functional activity (Smit et al., 2018).
3.7 | S-Predixcan gene-expression associations
Imputed gene expression was not significantly associated with the
OCD + compulsion symptoms combined phenotype in any of the
10 brain tissues. The expression of RP11-446E9 in Anterior Cingulate
Cortex almost reached significance after Bonferroni correction for the
number of genes tested within this tissue (p = .06). Comparing the
results from the PGC-OCD GWAS to the meta-analysis, Figure 5
shows the difference in log(p-values) for genes that fall under a range
of p-value thresholds, with values >0 indicating that the meta-analysis
has stronger effects. The figure highlights that increased significance
is not present for lower threshold values, but they are for the stronger
associations.
4 | DISCUSSION
We found a substantial and significant genetic correlation between the
existing OCD case–control GWAS and our GWAS of compulsion symp-
toms based on the abbreviated Padua Inventory. For this subscale—
which holds questions on behavioral symptoms related to checking
behavior, precision (ordering and counting), and contamination fear/
washing behavior—the genetic correlation was estimated at rG = 0.61,
p = .017. The obsessions subscale, on the other hand, was not signifi-
cantly genetically correlated with the PGC-OCD GWAS. This may
reflect the observation that the majority of OCD cases have washing
and checking symptoms, thus biasing the OCD GWAS toward these
symptoms. The remainder of the Padua Inventory items involves ques-
tions on thoughts and worries that may be less specific to OCD. Adding
all items scales in equal proportions to the GWAS (i.e., all available
Padua item scores) reduced the genetic correlation substantially.
Therefore, to optimally add symptom scale analyses to complement
case–control GWAS, it might be prudent to include only scores on the
questions interrogating the behavioral component of OCD. Note, how-
ever, that recent work has suggested that the absence of genome-wide
genetic correlation does not preclude the absence of any correlated
F IGURE 4 Significance of the enrichment of genes reported in
psychiatric/behavioral GWASs, as found in the top 250 genes in the
PGC-OCD GWAS and the current meta-analysis. Y-axis shows
Bonferroni corrected –log 10(p). Either equal significance or a strong
increase in the effect was observed when meta-analyzing OCD with
compulsive symptoms. ASD, autism spectrum disorders; BIP, bipolar
disorder; SCZ, schizophrenia; TS, Tourette's syndrome [Color figure
can be viewed at wileyonlinelibrary.com]
F IGURE 5 S-Predixcan resulted in stronger p-values after meta-
analyzing for the association of a gene's tissue expression with the
phenotype. The figure shows the ratio of the p-values of the meta-
analysis to the original GWAS (x-axis), log-transformed. This was
performed for genes reaching a specific threshold (x-axis) in the
original GWAS. The difference in log p-values for threshold 0.3–0.01,
indicating stronger effects in the meta-analysis. It also suggests that
adding compulsive symptoms only strengthens top genetic expression
effects in OCD. The average –log 10(p) difference across 10 brain
tissues is shown. *p < .05, **p < .01, ***p < .001 [Color figure can be
viewed at wileyonlinelibrary.com]
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SNP-effect, merely that the summed effect across all SNP effects is zero
(Frei et al., 2019). Such partial overlap could still play a role between the
obsessions subscale and the OCD GWAS. Future investigations could
establish whether positively and negatively correlated SNP effects are
indeed present between obsessive symptoms and OCD.
Based on the genetic correlation results, we ran the meta-analysis
with the PCG-OCD GWAS and the GWAS of compulsive symptoms.
This meta-analysis increased the sensitivity of the GWAS to find genes
in gene-based and gene-enrichment analyses. We observed two novel
discoveries at FDR p = .05 (ADCK1 and WDR7) in addition to the KIT
and GRID2 genes that were previously identified (International Obses-
sive Compulsive Disorder Foundation Genetics Collaborative (IOCDF-
GC) and OCD Collaborative Genetics Association Studies (OCGAS)
et al., 2018). SNPs in the WDR7 region have shown trend associations
with Tourette's syndrome/OCD (p = 4 × 10−6; Yu et al., 2015), but note
that this report included data from the current GWAS. In addition,
SNPs near WDR7 have been suggestively associated with alcohol
dependence (p = 8 × 10−6; Edwards et al., 2012). The ADCK1 gene is a
novel finding. An SNP near ADCK1 (rs740658277) has been reported
in relation to schizophrenia, schizophrenia symptom severity, and
response to paliperidone (p = 7 × 10−7; Li et al., 2017). Note that these
associations near the WDR7 and ADCK1 genes to psychiatric liabilities
are only suggestive, indicating that future research must confirm that
these variants are part of the genetic overlap between OCD and other
psychiatric disorders.
More substantial power increases were found in the enrichment
analysis using gene sets from GTEx and GWAS reports summarized in
the GWAS catalog. The OCD GWAS showed highly significant enrich-
ment of genes expressed in the anterior cingulate cortex and nucleus
accumbens. The involvement of these tissues is consistent with their
putative role in OCD, reward processing, and as contributing sub-
strates in the cortico-striato-thalamo-cortical circuitry known to be
affected in OCD (Denys et al., 2010; Hibar et al., 2018; van den
Heuvel et al., 2016). The effects were increased by meta-analyzing
the GWAS with the compulsive symptoms GWAS. In addition, the
meta-analysis showed increased enrichment of amygdala DEGs, again
consistent with the role of this subcortical structure in fear learning
and OCD (van den Heuvel et al., 2004).
Gene-set analysis revealed strong increases in the GWAS catalog
reported genes for traits known to be related to OCD. The original
PGC-OCD GWAS showed significant enrichment of genes linked to
schizophrenia, consistent with the known genetic overlap between the
disorders (Brainstorm Consortium, 2018; Bulik-Sullivan, Finucane, et al.,
2015; Martin, Taylor, & Lichtenstein, 2018). This effect increased by
over three orders of magnitude in significance after meta-analyzing
with the compulsive symptoms GWAS. Likewise, the significance of the
enrichment of “Tourette's or OCD” genes increased by over one order
of magnitude. The increased enrichment indicates that the top
250 genes were increasingly selective for psychiatric traits known to be
genetically correlated with OCD. This indicates that the expression of
compulsive behavior is selectively associated with these genes.
The increased enrichments in several psychiatric and brain-
expression gene sets were observed without a notable difference in
the magnitude of SNP effects between the original OCD GWAS and
the meta-analysis. The fact that these power increases were minor
after adding compulsive symptoms is likely a consequence of the small
size of the compulsion symptoms dataset (N < 10 k). Even so, the
power increases on an SNP-aggregate level observed here suggest
that a larger OCD symptoms GWAS could be useful for obtaining
increased SNP effects. Moreover, such a power increase is relatively
easy to obtain, requiring a relatively short questionnaire with just six
compulsion-symptom items from the Padua Inventory.
To summarize, we observed significant SNP-based genetic correla-
tions between the PGC-OCD GWAS and a GWAS of compulsive symp-
toms in a general population sample. This provided evidence that
compulsion symptoms substantially overlap with the genetic liability for
clinical diagnosis of OCD, and serves recent calls for doing genome-
wide symptom scale analyses to create insight into psychiatric disorder
etiology (Davis, 2019). We showed that meta-analyzing the OCD case–
control and compulsions symptoms GWAS results have added value in
the gene-based and gene-enrichment analyses. This included additional
significant genes in the gene-based test and subsequent enrichment
analysis of brain-expressed genes. These results bode well for larger
population-based samples to be merged with clinical samples to
increase power for finding the genetic mechanisms underlying OCD.
ACKNOWLEDGMENTS
We are indebted to the Psychiatric Genomics Consortium Tourette's
Syndrome/Obsessive–Compulsive Disorder workgroup (PGC
TS/OCD), in particular, Dongmei Yu and Carol Mathews, for making
the GWAS summary statistics available for download. We thank the
twins and their family members who participate in the studies of the
NTR. This study was supported by the Biobanking and Biomolecular
Resources Research Infrastructure BBMRI-NL (NWO 184.021.007
and 184.033.111); FP7- People-2012-ITN, project: TS-EUROTRAIN,
grant number 316978; ZonMW (Addiction) 31160008; and European
Research Council (ERC—230374); NWO-Groot 480-15-001/674:
Netherlands Twin Registry Repository; and Tourette Syndrome Asso-
ciation USA 2008: the genetic epidemiology of tics. Genotyping was
realized by grants Rutgers University Cell and DNA Repository (NIMH
U24 MH068457-06), the National Institutes of Health (NIH—R01
D0042157-01A1, R01 MH58799-03, MH081802, DA018673, R01
DK092127-04, Grand Opportunity grants 1RC2 MH089951, and
1RC2 MH089995); the Avera Institute for Human Genetics, Sioux
Falls, South Dakota (USA). D.I.B. acknowledges the Royal Netherlands
Academy of Science Professor Award (PAH/6635). K.J.H.V. is




D.J.A.S., D.C., and D.I.B. conceived and designed the analyses, and
drafted the manuscript, D.J.A.S., N.R.Z., A.d.B., and J.-J.H. performed
the analyses, H.F.I. provided analysis tools, D.D., E.J.C.d.G., and
K.J.H.V. revised the manuscript.
214 SMIT ET AL.
ORCID
Dirk J. A. Smit https://orcid.org/0000-0001-8301-8860
REFERENCES
Barbeira, A.N., Dickinson, S.P., Bonazzola, R., Zheng, J., Wheeler, H.E.,
Torres, J.M., … Im, H. K. (2018). Exploring the phenotypic conse-
quences of tissue specific gene expression variation inferred from
GWAS summary statistics. Nat Commun, 9, 1–20. https://doi.org/10.
1101/045260
Boomsma, D. I., Vink, J. M., van Beijsterveldt, T. C. E. M., Geus, E. J. C. d.,
Beem, A. L., Mulder, E. J. C. M., … van Baal, G. C. M. (2002). Netherlands
Twin Register: A focus on longitudinal research. Twin Research and
Human Genetics, 5(5), 401–406. https://doi.org/10.1375/twin.5.5.401
Brainstorm Consortium. (2018). Analysis of shared heritability in common
disorders of the brain. Science (New York, N.Y.), 360(6395), eaap8757.
https://doi.org/10.1126/science.aap8757
Bulik-Sullivan, B. K., Finucane, H. K., Anttila, V., Gusev, A., Day, F. R.,
Loh, P.-R., … Neale, B. M. (2015). An atlas of genetic correlations
across human diseases and traits. Nature Genetics, 47(11), 1236–1241.
https://doi.org/10.1038/ng.3406
Bulik-Sullivan, B. K., Loh, P.-R., Finucane, H. K., Ripke, S., Yang, J., Schizo-
phrenia Working Group of the Psychiatric Genomics Consortium, …
Neale, B. M. (2015). LD score regression distinguishes confounding
from polygenicity in genome-wide association studies. Nature Genetics,
47(3), 291–295. https://doi.org/10.1038/ng.3211
Burns, G. L., Keortge, S. G., Formea, G. M., & Sternberger, L. G. (1996).
Revision of the Padua Inventory of obsessive compulsive disorder
symptoms: Distinctions between worry, obsessions, and compulsions.
Behaviour Research and Therapy, 34(2), 163–173. https://doi.org/10.
1016/0005-7967(95)00035-6
Cath, D. C., van Grootheest, D. S., Willemsen, G., van Oppen, P., &
Boomsma, D. I. (2008). Environmental factors in obsessive–compulsive
behavior: Evidence from discordant and concordant monozygotic
twins. Behavior Genetics, 38(2), 108–120. https://doi.org/10.1007/
s10519-007-9185-9
Davis, L. K. (2019). Common knowledge: Shared genetics in psychiatry.
Nature Neuroscience, 22(3), 331–332. https://doi.org/10.1038/
s41593-019-0346-y
de Leeuw, C. A., Mooij, J. M., Heskes, T., & Posthuma, D. (2015). MAGMA:
Generalized gene-set analysis of GWAS data. PLoS Computational Biol-
ogy, 11(4), e1004219. https://doi.org/10.1371/journal.pcbi.1004219
Demontis, D., Walters, R. K., Martin, J., Mattheisen, M., Als, T. D.,
Agerbo, E., … Neale, B. M. (2019). Discovery of the first genome-wide
significant risk loci for attention deficit/hyperactivity disorder. Nature
Genetics, 51(1), 63–75. https://doi.org/10.1038/s41588-018-0269-7
den Braber, A., Zilh~ao, N. R., Fedko, I. O., Hottenga, J.-J., Pool, R.,
Smit, D. J. A., … Boomsma, D. I. (2016). Obsessive–compulsive symp-
toms in a large population-based twin-family sample are predicted by
clinically based polygenic scores and by genome-wide SNPs. Transla-
tional Psychiatry, 6(2), e731. https://doi.org/10.1038/tp.2015.223
Denys, D., Mantione, M., Figee, M., van den Munckhof, P., Koerselman, F.,
Westenberg, H., … Schuurman, R. (2010). Deep brain stimulation of
the nucleus accumbens for treatment-refractory obsessive–
compulsive disorder. Archives of General Psychiatry, 67(10),
1061–1068. https://doi.org/10.1001/archgenpsychiatry.2010.122
Edwards, A. C., Aliev, F., Bierut, L. J., Bucholz, K. K., Edenberg, H.,
Hesselbrock, V., … Dick, D. M. (2012). Genome-wide association study of
comorbid depressive syndrome and alcohol dependence. Psychiatric
Genetics, 22(1), 31–41. https://doi.org/10.1097/YPG.0b013e32834acd07
Frei, O., Holland, D., Smeland, O. B., Shadrin, A. A., Fan, C. C., Maeland, S.,
… Dale, A. M. (2019). Bivariate causal mixture model quantifies poly-
genic overlap between complex traits beyond genetic correlation.
Nature Communications, 10(1), 1–11. https://doi.org/10.1038/
s41467-019-10310-0
Gamazon, E. R., Wheeler, H. E., Shah, K. P., Mozaffari, S. V., Aquino-
Michaels, K., Carroll, R. J., … Im, H. K. (2015). A gene-based association
method for mapping traits using reference transcriptome data. Nature
Genetics, 47(9), 1091–1098. https://doi.org/10.1038/ng.3367
Hibar, D. P., Cheung, J. W., Medland, S. E., Mufford, M. S., Jahanshad, N.,
Dalvie, S., … Enhancing Neuro Imaging Genetics through Meta Analy-
sis (ENIGMA) Consortium and International Obsessive Compulsive
Disorder Foundation Genetics Collaborative (IOCDF-GC). (2018). Sig-
nificant concordance of genetic variation that increases both the risk
for obsessive–compulsive disorder and the volumes of the nucleus
accumbens and putamen. The British Journal of Psychiatry: The Journal
of Mental Science, 213(1), 430–436. https://doi.org/10.1192/bjp.
2018.62
Iervolino, A. C., Rijsdijk, F. V., Cherkas, L., Fullana, M. A., & Mataix-Cols, D.
(2011). A multivariate twin study of obsessive–compulsive symptom
dimensions. Archives of General Psychiatry, 68(6), 637–644. https://doi.
org/10.1001/archgenpsychiatry.2011.54
International Obsessive Compulsive Disorder Foundation Genetics Collab-
orative (IOCDF-GC) and OCD Collaborative Genetics Association
Studies (OCGAS), Arnold, P. D., Askland, K. D., Barlassina, C.,
Bellodi, L., Bienvenu, O. J., … Zai, G. (2018). Revealing the complex
genetic architecture of obsessive–compulsive disorder using meta-
analysis. Molecular Psychiatry, 23(5), 1181–1188. https://doi.org/10.
1038/mp.2017.154
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., &
Walters, E. E. (2005). Lifetime prevalence and age-of-onset distribu-
tions of DSM-IV disorders in the National Comorbidity Survey Replica-
tion. Archives of General Psychiatry, 62(6), 593–602. https://doi.org/
10.1001/archpsyc.62.6.593
Lee, J. J., McGue, M., Iacono, W. G., & Chow, C. C. (2018). The accu-
racy of LD score regression as an estimator of confounding and
genetic correlations in genome-wide association studies. Genetic
Epidemiology, 42(8), 783–795. https://doi.org/10.1002/gepi.
22161
Li, Q., Wineinger, N. E., Fu, D.-J., Libiger, O., Alphs, L., Savitz, A., …
Schork, N. J. (2017). Genome-wide association study of paliperidone
efficacy. Pharmacogenetics and Genomics, 27(1), 7–18. https://doi.org/
10.1097/FPC.0000000000000250
Martin, J., Taylor, M. J., & Lichtenstein, P. (2018). Assessing the evidence
for shared genetic risks across psychiatric disorders and traits. Psycho-
logical Medicine, 48(11), 1759–1774. https://doi.org/10.1017/
S0033291717003440
Pauls, D. L., Alsobrook, J. P., Goodman, W., Rasmussen, S., &
Leckman, J. F. (1995). A family study of obsessive–compulsive disor-
der. The American Journal of Psychiatry, 152(1), 76–84. https://doi.org/
10.1176/ajp.152.1.76
Smit, D.J.A., Wright, M.J., Meyers, J.L., Martin, N.G., Ho, Y.Y.W., Malone,
S.M., … Boomsma, D.I. 2018. Genome-wide association analysis links
multiple psychiatric liability genes to oscillatory brain activity. Human
Brain Mapping,39,4183–4195.
van den Heuvel, O. A., van Wingen, G., Soriano-Mas, C., Alonso, P.,
Chamberlain, S. R., Nakamae, T., … Veltman, D. J. (2016). Brain cir-
cuitry of compulsivity. European Neuropsychopharmacology: The Journal
of the European College of Neuropsychopharmacology, 26(5), 810–827.
https://doi.org/10.1016/j.euroneuro.2015.12.005
van den Heuvel, O. A., Veltman, D. J., Groenewegen, H. J., Dolan, R. J.,
Cath, D. C., Boellaard, R., … van Dyck, R. (2004). Amygdala activity in
obsessive–compulsive disorder with contamination fear: A study with
oxygen-15 water positron emission tomography. Psychiatry Research:
Neuroimaging, 132(3), 225–237. https://doi.org/10.1016/j.
pscychresns.2004.06.007
van Grootheest, D. S., Cath, D. C., Beekman, A. T., & Boomsma, D. I.
(2005). Twin studies on obsessive–compulsive disorder: A review.
Twin Research and Human Genetics, 8(5), 450–458. https://doi.org/10.
1375/twin.8.5.450
SMIT ET AL. 215
van Grootheest, D. S., Cath, D. C., Beekman, A. T., & Boomsma, D. I.
(2007). Genetic and environmental influences on obsessive–
compulsive symptoms in adults: A population-based twin-family study.
Psychological Medicine, 37(11), 1635–1644. https://doi.org/10.1017/
S0033291707000980
van Oppen, P. (1992). Obsessions and compulsions: Dimensional structure,
reliability, convergent and divergent validity of the Padua inventory.
Behaviour Research and Therapy, 30(6), 631–637. https://doi.org/10.
1016/0005-7967(92)90008-5
Watanabe, K., Taskesen, E., van Bochoven, A., & Posthuma, D. (2017).
Functional mapping and annotation of genetic associations with
FUMA. Nature Communications, 8(1), 1826. https://doi.org/10.1038/
s41467-017-01261-5
Yang, J., Lee, S. H., Goddard, M. E., & Visscher, P. M. (2011). GCTA: A tool
for genome-wide complex trait analysis. The American Journal of Human
Genetics, 88(1), 76–82. https://doi.org/10.1016/j.ajhg.2010.11.011
Yu, D., Mathews, C. A., Scharf, J. M., Neale, B. M., Davis, L. K.,
Gamazon, E. R., … Pauls, D. L. (2015). Cross-disorder genome-wide
analyses suggest a complex genetic relationship between Tourette's
syndrome and OCD. The American Journal of Psychiatry, 172(1), 82–93.
https://doi.org/10.1176/appi.ajp.2014.13101306
Zilh~ao, N. R., Smit, D. J. A., den Braber, A., Dolan, C. V., Willemsen, G.,
Boomsma, D. I., & Cath, D. C. (2015). Genetic and environmental Contri-
butions to stability in adult obsessive compulsive behavior. Twin Research
and Human Genetics, 18(1), 52–60. https://doi.org/10.1017/thg.2014.77
SUPPORTING INFORMATION
Additional supporting information may be found online in the
Supporting Information section at the end of this article.
How to cite this article: Smit DJA, Cath D, Zilh~ao NR, et al.
Genetic meta-analysis of obsessive–compulsive disorder and
self-report compulsive symptoms. Am J Med Genet Part B.
2020;183B:208–216. https://doi.org/10.1002/ajmg.b.32777
216 SMIT ET AL.
